關鍵數據
23.040今開
23.460最高
46.93K成交量
虧損本益比TTM
42.59本益比動
--股利TTM
0.09%換手率
23.070昨收
23.040最低
1.09M成交額
虧損本益比靜
3.17市淨率
0.00%股息率 TTM
-4.63%ROA
35.87052週最高
0.04量比
-20.21M淨利潤
50.12M總股本
-0.4200每股盈餘TTM
1.23Beta
-5.99%ROE
15.59052週最低
1.73%振幅
74.55%毛利率
1.16B總市值
2.90回報/風險
3.45%風險率
最新
分析
財報
電話會議紀要

即將為您帶來更多新聞,敬請期待。 。 。
STAAR Surgical Co評分
0.08與上次評分對比預測6.50
財務診斷8.51
技術分析4.05
公司估值9.24
機構認同度10.00
風險評估6.74
分析師評級
持有評級
27.900目標均價
+20.94%漲幅空間
STAAR Surgical Co 最新財報電話會記錄
STAAR Surgical (STAA) 2026 年第二季法說會:中國與 EVO Plus 帶動營收成長 111%
STAAR Surgical 2026 年第二季銷售額在中國與 EVO Plus 的帶動下成長 111% 至 9,350 萬美元。淨利達 810 萬美元,現金增加至 1.815 億美元。
財務指標
貨幣: USD

由於公司未披露,未能獲取相關數據
貨幣: USD

由於公司未披露,未能獲取相關數據
STAAR Surgical Co 簡介
STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company’s principal products are ICLs used in refractive surgery, including its EVO family of lenses.
行業醫療設備與耗材
公司代碼STAA
員工數量1157
國家United States of America
持股情況
| 持股股東 | 佔比 |
|---|
| Broadwood Capital, Inc. | 32.38% |
|---|
| BlackRock Institutional Trust Company, N.A. | 13.44% |
|---|
| Yunqi Capital Limited | 6.54% |
|---|
| Madison Avenue Partners LP | 5.73% |
|---|
| 股東類型 | 佔比 |
|---|
| Hedge Fund | 53.68% |
|---|
| Investment Advisor | 31.49% |
|---|
| Investment Advisor/Hedge Fund | 21.11% |
|---|
| Research Firm | 6.23% |
|---|
常見問題
STAAR Surgical Co(STAA)的當前股價是多少?
STAAR Surgical Co(STAA)的當前股價是 23.14。
STAAR Surgical Co 的股票代碼是什麼?
STAAR Surgical Co的股票代碼是STAA。
STAAR Surgical Co股票的52週最高點是多少?
STAAR Surgical Co股票的52週最高點是35.87。
STAAR Surgical Co股票的52週最低點是多少?
STAAR Surgical Co股票的52週最低點是15.59。
STAAR Surgical Co的市值是多少?
STAAR Surgical Co的市值是1.16B。
現在STAAR Surgical Co(STAA)的股票是買入、持有還是賣出?
根據分析師評級,STAAR Surgical Co(STAA)的總體評級為signal_hold,目標價格為27.90。
STAAR Surgical Co(STAA)股票的每股收益(EPS TTM)是多少
STAAR Surgical Co(STAA)股票的每股收益(EPS TTM)是-0.42。